The effect of subcutaneous deferoxamine on the cardiac profile of thalassemia major: a five-year study.
D000293:Adolescent; D000328:Adult; D001145:Arrhythmias, Cardiac / Q000209:etiology / Q000503:physiopathology; D002648:Child; D002675:Child, Preschool; D003676:Deferoxamine / Q000008:administration & dosage* / Q000627:therapeutic use; D004452:Echocardiography; D004562:Electrocardiography; D005260:Female; D006321:Heart / Q000503:physiopathology*; D006331:Heart Diseases / Q000209:etiology* / Q000503:physiopathology; D006801:Humans; D007279:Injections, Subcutaneous; D007501:Iron / Q000378:metabolism / Q000652:urine; D008297:Male; D013318:Stroke Volume; D013789:Thalassemia / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology
D007501:Iron; D003676:Deferoxamine